DIOSynVax
3 stories
-
healthAI-Designed ‘Universal’ Coronavirus Vaccine Shows Promise in First Human Trial
A groundbreaking AI-designed vaccine, pEVAC-PS, is safe and well-tolerated in Phase I trials, offering broad protection against multiple coronaviruses, including future variants.
-
healthFirst AI-Designed Vaccine Passes Human Trial at Cambridge
Phase 1 trial shows AI-crafted antigen is safe and triggers broad coronavirus immunity, including against future bat-borne strains.
-
healthWorld-First AI-Designed Vaccine Passes Human Trial at Cambridge
An AI-engineered vaccine, developed at Cambridge, successfully completed a Phase I trial, triggering broad immunity against coronaviruses.